WO2025040750 - A DENTAL CARE COMPOSITION FOR ANIMALS
National phase entry is expected:
Publication Number
WO/2025/040750
Publication Date
27.02.2025
International Application No.
PCT/EP2024/073560
International Filing Date
22.08.2024
Title **
[English]
A DENTAL CARE COMPOSITION FOR ANIMALS
[French]
COMPOSITION DE SOINS DENTAIRES POUR ANIMAUX
Applicants **
NOVOZYMES A/S
Inventors
SEGURA, Dorotea, Raventos
TOVBORG, Morten
Priority Data
23192765.8
22.08.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2069 | |
| EPO | Filing, Examination, Granting | 8321 | |
| Japan | Filing, Examination, Granting | 2170 | |
| South Korea | Filing, Examination, Granting | 2060 | |
| USA | Filing, Examination, Granting | 7740 |
Total:
22,360
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a composition comprising a combination of enzymes comprising alpha amylases, glucanases and/or xylanases, and lipases and/or phosphodiesterases, use of the composition as medicaments, use of the composition in treatment of oral disease, methods of treatment comprising administering the composition to animals, methods of preventing or removing oral biofilm comprising contacting an oral biofilm with the composition, methods for reducing the risk of oral biofilm formation, methods for removing the oral biofilm formed, and kits of parts comprising the composition.[French]
La présente invention concerne une composition comprenant une combinaison d'enzymes comprenant des alpha-amylases, des glucanases et/ou des xylanases, et des lipases et/ou des phosphodiestérases, l'utilisation de la composition en tant que médicaments, l'utilisation de la composition dans le traitement d'une maladie buccale, des méthodes de traitement comprenant l'administration de la composition à des animaux, des procédés de prévention ou d'élimination du biofilm buccal comprenant la mise en contact d'un biofilm buccal avec la composition, des procédés de réduction du risque de formation de biofilm buccal, des procédés d'élimination du biofilm buccal formé, et des kits de pièces comprenant la composition.